W.C. Voegtli
Alexion Pharmaceuticals (United States)(US)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Kinase Regulation and GTPase Signaling, Pancreatic function and diabetes, Metal-Catalyzed Oxygenation Mechanisms, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition(2010)320 cited
- → The Structure of Aip1p, a WD Repeat Protein That Regulates Cofilin-mediated Actin Depolymerization(2003)89 cited
- → Structure of the Bacteriophage λ Ser/Thr Protein Phosphatase with Sulfate Ion Bound in Two Coordination Modes,(2000)89 cited
- → A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293(2017)88 cited
- → Rational Reprogramming of the R2 Subunit of Escherichia coli Ribonucleotide Reductase into a Self-Hydroxylating Monooxygenase(2001)68 cited
- → Pyrazolopyridine Inhibitors of B-RafV600E. Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors(2011)66 cited